Prevention of everolimus/exemestane (EVE/EXE) stomatitis in postmenopausal (PM) women with hormone receptor-positive (HR+) metastatic breast cancer (MBC) using a dexamethasone-based mouthwash (MW): Results of the SWISH trial.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: UCSF Helen Diller Family Comprehensive Cancer Center, Highlands Oncology Group, University of California, Los Angeles, Saint Luke's Hospital, Cancer Treatment Centers of America, Kaiser Permanente, Kaiser Permanente Gaithersburg Medical Center, University of California, Irvine, UC Irvine Chao Family Comprehensive Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, University of Maryland Medical Center, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4240042710
